difference in semaglutide and mounjaro vs. Ozempic: What's a Better Weight Loss Drug? — Kass Precision Medicine what's the difference between semaglutide

Ongoing #GLP1 -RA Trials on #ASCVD #SELECT: Semaglutide vs Placebo in Patients With Obesity and ASCVD Without DM #SOUL: Semaglutide vs Placebo in Adults With T2D With ASCVD or CKD #SURPASS-CVOT: Tirzepatide vs Dulaglutide in Patients With T2D and ASCVD #SURMOUNT-MMO:

Were now seeing a real shift: from weekly injections to once-daily pills Two oral GLP-1 options are now leading this transition: #Wegovy pill (oral semaglutide) first to market #Foundayo (orforglipron) newest entrant But heres what you must know

As presented at the American Diabetes Association Meeting: this randomized phase 2b trial in 230 adults with overweight or obesity shows that aleniglipron, an oral small-molecule GLP1-RA, led to up to 11.3% body-weight loss compared with placebo after 36 weeks of treatment.

A day after Eli Lilly gained FDA approval for its obesity pill Foundayo, Novo Nordisk is fighting back with an analysis that it says shows the superiority of its own oral drug.

Long-term methods These methods provide a long-term, permanent reduction in PCOS-related facial hair